Hostname: page-component-7b7567c8c-8tzhz Total loading time: 0 Render date: 2026-11-19T20:02:13.831Z Has data issue: false hasContentIssue false

The Dexamethasone Suppression Test in Generalised Anxiety Disorder

Published online by Cambridge University Press:  29 January 2018

Edward E. Schweizer*
Affiliation:
Department of Psychiatry, University of Pennsylvania, 203 Piersol Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104
Charlotte M. Swenson
Affiliation:
Department of Psychiatry, University of Pennsylvania, 203 Piersol Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104
Andrew Winokur
Affiliation:
Department of Psychiatry, University of Pennsylvania, 203 Piersol Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104
Karl Rickels
Affiliation:
University of Pennsylvania, 203 Piersol Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104
Greg Maislin
Affiliation:
Department of Statistics, University of Pennsylvania, 203 Piersol Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104
*
Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The dexamethasone suppression test was performed on 79 patients with a diagnosis of generalised anxiety disorder. A non-suppression rate of 27% was obtained, comparable to that found in out-patient major depression but notably higher than previous reports in panic disorder. No good clinical predictors of non-suppression were discovered, nor was the co-occurrence of depression sufficient to account for the finding.

Information

Type
Papers
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.